Back to Search
Start Over
Pfizer and BioNTech commence trial of COVID-19 vaccine targeting Omicron variant
- Source :
- M2 Pharma. January 25, 2022
- Publication Year :
- 2022
-
Abstract
- M2 PHARMA-January 25, 2022-Pfizer and BioNTech commence trial of COVID-19 vaccine targeting Omicron variant (C)2022 M2 COMMUNICATIONS US pharmaceutical company Pfizer Inc (NYSE:PFE) and its partner, German biotechnology company BioNTech [...]
- Subjects :
- BioNTech SE -- Product development -- Planning
Pfizer Inc. -- Product development -- Planning
Biotechnology industry -- Product development -- Planning
Clinical trials
Vaccines -- Product development -- Planning
Pharmaceutical industry -- Product development -- Planning
Company business planning
Chemistry
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.690393836